A subscription to JoVE is required to view this content. Sign in or start your free trial.

Research Article

Visual Bibliometric Analysis of Research Hotspots and Trends in Antimicrobial Resistance in China

101 views

⸱

DOI:

10.3791/72404

⸱

September 8th, 2026

 ,  , 

In This Article

Summary

This bibliometric analysis maps antimicrobial resistance research trends and emerging hotspots in China from 2016–2025 using CiteSpace. The findings highlight increasing attention to novel therapeutics and technology-enabled approaches, alongside contrasting MRSA and CRKP resistance trends, emphasizing the need for continued surveillance and targeted antimicrobial stewardship.

Abstract

To systematically analyze the research landscape of antimicrobial resistance (AMR) in China from 2016–2025, identify hotspots, and detect emerging trends using bibliometric visualization techniques. We compiled 3,096 publications from the Web of Science Core Collection (including Science Citation Index Expanded, SCI-E) and China National Knowledge Infrastructure (CNKI). Using CiteSpace, we performed co-authorship network analysis, keyword co-occurrence mapping, and cluster analysis employing the Log-Likelihood Ratio (LLR) algorithm. Burst detection via Kleinberg's algorithm identified research frontiers, while modularity Q (>0.3) and silhouette metrics validated network structural quality. Rising from 357 in 2016 to 365 in 2022, with accelerated growth following the 2019–2022 period. Six major research clusters emerged with significant structural validity (modularity Q = 0.8108). Burst analysis identified mobilized colistin resistance-1 (mcr-1, burst strength 9.12) and carbapenemase (8.52) as the strongest emerging signals. Resistance surveillance revealed divergent trends: carbapenem-resistant Klebsiella pneumoniae increased alarmingly from 5.6% to 20.0%, whereas methicillin-resistant Staphylococcus aureus declined from 48.8% to 25.8%. Author network analysis revealed a highly centralized structure with limited cross-regional collaboration. Novel therapeutics, including antimicrobial peptides, phage therapy, and machine learning applications, demonstrated significant emergence. Overall, the bibliometric patterns suggest that AMR research in China has evolved from descriptive surveillance toward mechanistic investigation and increasing attention to innovative interventions. The contrasting decline in methicillin-resistant Staphylococcus aureus and rise in carbapenem-resistant pathogens highlight the need for continued national surveillance, stronger inter-regional collaboration, targeted antimicrobial stewardship, and cautious translation of emerging technologies into clinical practice.

Introduction

Antimicrobial resistance (AMR) poses a critical threat to global public health, with the World Health Organization identifying it as one of the top ten health threats facing humanity1. The economic burden of AMR is substantial, with projections suggesting that by 2050, resistant infections could cause 10 million deaths annually worldwide if current trends continue2. The fundamental mechanisms of antimicrobial resistance in bacteria involve complex genetic and phenotypic adaptations, including enzymatic drug modification, target site alterations, efflux pump overexpression, and biofilm formation, which collectively threaten the efficacy of existing therapeutic armamentarium3. Recent global assessments have further emphasized the expansive scope of this challenge, with antimicrobial resistance now recognized as a complex ecological phenomenon requiring coordinated action across human health, animal agriculture, and environmental sectors4. AMR also has broader implications for sustainable development, including environmental and socioeconomic targets5. The challenge is particularly acute in combating resistance in malaria, HIV, and tuberculosis, where multidrug-resistant strains threaten decades of progress in infectious disease control6. Historical analyses of AMR epidemiology in China have documented distinctive characteristics compared to Western populations, including unique resistance gene profiles and transmission dynamics shaped by healthcare practices and antibiotic consumption patterns7.

China, with its large population and substantial antibiotic consumption, faces particularly severe AMR challenges. The per capita antibiotic use in China remains significantly higher than in many European countries, creating selective pressure that drives resistance development8. Recognizing the severity of this crisis, the Chinese government has implemented the National Action Plan to Contain Antimicrobial Resistance (2016–2020, 2022–2025) and established the China Antimicrobial Resistance Surveillance System (CARSS) to monitor resistance patterns nationwide9. From a regional perspective, Southeast Asia has emerged as a critical hotspot for AMR research and dissemination, with bibliometric analyses revealing rapidly growing research output paralleling China's trajectory10. Global trends and projections suggest that without decisive intervention, the mortality burden of AMR will disproportionately affect middle-income countries, with some projections indicating that the Asia-Pacific region may account for nearly half of all resistance-related deaths by mid-century11. These sobering forecasts have catalyzed international commitments to antimicrobial stewardship, though implementation gaps persist between policy formulation and clinical practice worldwide12. These initiatives have generated extensive data on resistance epidemiology, molecular mechanisms, and clinical outcomes, providing a rich source for bibliometric analysis. Recent One Health frameworks, therefore, emphasize coordinated interventions across human health, animal health, agriculture, and environmental sectors, supported by antimicrobial stewardship and rapid diagnostic technologies13.

Bibliometric analysis, utilizing mathematical and statistical methods to quantitatively analyze published literature, enables researchers to uncover research hotspots, track evolutionary trajectories, and predict future directions14. Visualization tools such as CiteSpace transform complex citation data into intuitive knowledge maps, revealing hidden patterns in scientific literature15. Previous bibliometric studies have mapped research trends in specific AMR domains, including global antifungal resistance research16. However, comprehensive bibliometric analysis integrating Chinese- and English-language research on AMR in China remains limited. In contrast to previous bibliometric analyses focused on specific AMR domains, the present study integrates Chinese-language CNKI and English-language Web of Science records and separately contextualizes the bibliometric findings using national CARSS surveillance trends. This study aims to provide a systematic bibliometric analysis of AMR research in China from 2016–2025, utilizing CiteSpace software to generate knowledge maps and provide evidence-based recommendations for future research priorities and policy development. This combined design provides a bilingual view of the research landscape while allowing bibliometric trends to be interpreted alongside, but independently from, national resistance-surveillance data.

Access restricted. Please log in or start a trial to view this content.

Protocol

Data sources

A comprehensive literature search was conducted across both international and domestic databases to ensure global coverage of AMR research related to China. For international literature, we systematically searched the Web of Science Core Collection (including Science Citation Index Expanded, SCI-E) and the China National Knowledge Infrastructure (CNKI) from January 1, 2016, to December 31, 2025. Exact Boolean Query for SCI-E: TS = ((“antimicrobial resistance” OR “antibiotic resistance” OR “drug resistance”) AND (“China” OR “Chinese” OR “Mainland China”)). For CNKI, the Subject field was searched using the Chinese-language equivalents of “antibiotic resistance,” “antimicrobial resistance,” and “drug resistance,” combined with “China.” No formal keyword-synonym merging or thesaurus-based preprocessing was performed before the CiteSpace analysis. The final search was executed on April 28, 2026, to allow sufficient time for publications issued through December 31, 2025, to be indexed in the databases. The database publication-year filter was restricted to 2016–2025. Records labeled as Early Access were additionally checked during screening, and articles with a first online publication date in 2026 were excluded from the analysis. Keyword labels were checked against the original CiteSpace output to ensure consistent terminology in the text, tables, and figures.

For the CNKI search, 983 records were retrieved from the Peking University Core Journals (PKU Core), 802 from the Chinese Science Citation Database (CSCD), and 462 from the World Journal Clout Index (WJCI). Because a single article may be indexed in more than one of these categories, these numbers represent category-specific retrieval records and are not mutually exclusive publication counts. The three record sets were therefore merged before eligibility screening. Duplicate entries were identified first by exact DOI matching. For records without a DOI, normalized article titles were compared together with the first-author name and publication year. Records with incomplete or inconsistent metadata were reviewed manually. When the same article appeared in two or more CNKI indexing categories, it was retained only once in the combined CNKI dataset, irrespective of the number of categories in which it was indexed. After within-CNKI deduplication and eligibility screening, 1,096 unique Chinese-language articles were retained. No journal impact-factor threshold was applied, because the purpose of this study was to characterize the overall AMR research landscape rather than to restrict the corpus according to journal prestige. Formal methodological-quality or risk-of-bias assessment of individual publications was not performed because the objective of this study was to characterize the overall bibliometric landscape rather than to evaluate study-level methodological quality.

Across SCI-E and CNKI, 5,286 records were identified initially. The same DOI-, title-, author-, and year-based criteria were subsequently applied to identify potential overlaps between the CNKI and Web of Science datasets. A total of 2,190 records were removed during combined deduplication and eligibility screening, leaving 3,096 publications for analysis. The complete literature identification, screening, and inclusion process is presented in Supplementary Figure 1.

Inclusion criteria were: studies focusing on bacterial AMR in China; articles reporting resistance rates, molecular epidemiology, clinical outcomes, or intervention strategies; and publications between January 1, 2016, and December 31, 2025. Duplicate records, 2026 publications, reviews, or meta-analyses without original datasets, and studies limited to veterinary or environmental AMR without a human-health component were excluded. Reviews and meta-analyses without new primary datasets were excluded because the analysis was designed to characterize original research output. Restricting the corpus to original research improves the comparability of bibliometric indicators, including publication counts, co-authorship patterns, keyword frequencies, and citation-related measures, because evidence-synthesis articles aggregate prior studies and may have substantially different citation and keyword profiles. After removing duplicates across databases and screening titles/abstracts, a total of 3,096 publications were included for bibliometric analysis, comprising 1,096 Chinese-language articles (35.4%) and 2000 English-language publications (64.6%).

Analytical methods

CiteSpace (Drexel University, Philadelphia, PA, USA)17 was used for bibliometric analysis. The time span was 2016–2025 with a 1-year slice length. Node types were selected separately for author, institution, and keyword analyses. Node selection used the g-index with k = 10; the displayed configuration also used LRF = 2.5, L/N = 10, LBY = 5, and e = 1.0. Pathfinder pruning was applied to the author, keyword, and cluster networks to reduce redundant links while retaining the principal network structure. The 1-year time slice was selected to preserve annual changes within the 10-year study window.

Four main analytical modules were utilized: co-authorship analysis to map collaboration networks among authors and institutions; keyword co-occurrence analysis to identify research themes and their relationships; cluster analysis using the Log-Likelihood Ratio (LLR) algorithm to extract thematic clusters with automatic labeling; and burst detection using Kleinberg’s algorithm to identify emerging trends and research frontiers. Network metrics, including modularity Q and mean silhouette S, were used to evaluate cluster quality. A modularity Q value greater than 0.3 indicates a meaningful community structure, whereas a mean silhouette value greater than 0.7 indicates high within-cluster consistency and reliable cluster assignment18.

Statistical analysis of resistance trends

Resistance rate trends for major pathogens were derived from the China Antimicrobial Resistance Surveillance System (CARSS) annual reports (2016–2025), which aggregate data from participating sentinel hospitals nationwide. These surveillance data were analyzed independently of the bibliometric corpus and were not extracted from, pooled across, or included among the 3,096 Web of Science and CNKI publications used for the CiteSpace analyses.

For each pathogen–antimicrobial combination, we extracted the annual resistance rate (percentage of non-duplicate isolates resistant to the specified agent), the total number of isolates tested (denominator), and the number of sentinel hospitals contributing data. Susceptibility testing was performed using standardized broth microdilution or disk diffusion methods, with interpretations based on Clinical and Laboratory Standards Institute (CLSI) guidelines (M100 documents, editions 2016–2025).

To assess temporal trends, we performed linear regression analysis with the resistance rate as the dependent variable and year as the independent variable, covering the full 10-year period (2016–2025). The regression slope (β) and coefficient of determination (R2) were calculated for each pathogen–antimicrobial pair. To account for potential changes in surveillance coverage (e.g., expansion from 1,398 hospitals in 2016 to 2,349 hospitals in 2025), we also performed sensitivity analyses weighting each year's resistance rate by the inverse of the number of participating hospitals and by the geographic distribution of reporting sites. These weighted models yielded trend directions and significance levels consistent with the unweighted analyses; therefore, unweighted results are presented for simplicity and interpretability. All statistical analyses were performed using R version 4.3.2 (R Foundation for Statistical Computing, Vienna, Austria). A two-sided p-value <0.05 was considered statistically significant.

Access restricted. Please log in or start a trial to view this content.

Results

Publication trends

A total of 3,096 publications were included in the analysis. Total annual output increased from 357 publications in 2016 to a peak of 365 in 2022 and subsequently declined continuously to 146 in 2025 (Figure 1). English-language output increased from 130 publications in 2016 to 295 in 2022 before decreasing to 69 in 2025. Chinese-language output decreased from 227 publications in 2016 to 93 in 2019, increased during 2020–2021, ...

Access restricted. Please log in or start a trial to view this content.

Discussion

The bibliometric patterns suggest that AMR research in China gradually broadened from descriptive surveillance and pathogen characterization toward resistance mechanisms, genomic approaches, and intervention-oriented research. The overlapping keyword clusters and burst periods indicate cumulative thematic diversification rather than three discrete and mutually exclusive stages. The timing of these changes overlapped with the National Action Plans to Contain Antimicrobial Resistance for 2016–2020 and 2022–2025...

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors declare that generative artificial intelligence (AI) tools were used in the preparation of this manuscript as follows: Grammarly (version 1.2.3) was used for language polishing and grammatical correction of the final manuscript draft; OpenAI's ChatGPT (GPT-4, accessed via API on March 15, 2026) was used to assist with bibliometric data cleaning and to generate initial Python scripts for data preprocessing; No AI tool was used to generate the scientific findings, interpret results, or formulate the conclusions; All figures and tables were generated directly from CiteSpace and R 4.3.2 outputs without AI-assisted generation. The authors have reviewed and verified all content generated with AI assistance and take full responsibility for the accuracy and integrity of the manuscript.

Acknowledgements

The authors sincerely thank the Infectious Department at The Affiliated People’s Hospital of Ningbo University (Yinzhou People’s Hospital) for providing the administrative and technical support required to complete this manuscript.

This research was funded by Ningbo Medical and Health Leading Academic Discipline Project (Grant No.2026-A42).

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
CiteSpaceDrexel University, Philadelphia, PA, USAversion 6.4.R1To perform comprehensive bibliometric analysis, including co-authorship analysis, keyword co-occurrence analysis, cluster analysis, and burst detection.
China National Knowledge Infrastructure (CNKI)China National Knowledge InfrastructureNot applicableTo compile research articles provided by Chinese domestic sources.
RR softwareversion 4.3.2
Web of Science Core Collection (SCI-E)Web of ScienceNot applicableTo systematically search and retrieve international literature.

References

  1. World Health Organization. Global action plan on antimicrobial resistance. World Health Organization; Geneva; 2015.
  2. O’Neill J. Tackling drug-resistant infections globally: Final report and recommendations. 2016.
  3. Bockstael K, Van Aerschot A. Antimicrobial resistance in bacteria. Open Med. 2009;4(2):141–155.
  4. Okeke IN, de Kraker MEA, Van Boeckel TP. The scope of the antimicrobial resistance challenge. Lancet. 2024;403(10442):13.
  5. Bhattacharya R, et al. Impact of antimicrobial resistance on sustainable development goals and the integrated strategies for meeting environmental and socio-economic targets. Environ Prog Sustain Energy. 2024;43(1):e14320.
  6. Duffey M, Shafer RW, Timm J. Combating antimicrobial resistance in malaria, HIV and tuberculosis. Nat Rev Drug Discov. 2024;23(6):19.
  7. Xiao YH, et al. Epidemiology and characteristics of antimicrobial resistance in China. Drug Resist Updat. 2011;14(4):236–241.
  8. Yin X, et al. A systematic review of antibiotic utilization in China. J Antimicrob Chemother. 2013;68(11):2445–2452.
  9. National Health Commission of the People’s Republic of China. National action plan to contain antimicrobial resistance (2022–2025). 2022.
  10. Borromeo AS, Manaloto AM, Antonio RP. Southeast Asian landscape of antimicrobial resistance research (2014–2024): A bibliometric analysis. J Glob Antimicrob Resist. 2025;45(c):125–132.
  11. Fekadu A, Woldeamanuel Y, Hailu A. Global trends and projections in antimicrobial resistance. Lancet. 2025;(10493):405.
  12. Selvaraj V, Sudhakar S, Sekaran S. Global trends and projections in antimicrobial resistance. Lancet. 405(10493):413–414.
  13. Bhattacharya R, et al. A One health plan to combat antimicrobial resistance for improving global health through sustainable development. Discov Public Health. 2025;22(1):521.
  14. Chen C, Leydesdorff L. Patterns of connections and movements in dual-map overlays: A new method of publication portfolio analysis. J Assoc Inf Sci Technol. 2014;65(2):334–351.
  15. Persson O, Danell R, Schneider JW. Using the BIBLIOMETRIX package for bibliometric analysis. Scientometrics. 2009;80(2):253–275.
  16. Bhattacharya R, et al. Bibliometric assessment of the global research trends in antimicrobial resistance for fungal species. Ind Biotechnol. 2024;20(5):212–224.
  17. Zhu J, Zhou Y, Ding YQ. Visualization analysis of hotspots and trends of drug control institutions in China based on bibliometrics. Chin J Mod Appl Pharm. 2023;40(18):2591–2599.
  18. Chen C. Science mapping: A systematic review of the literature. J Data Inf Sci. 2017;2(2):1–40.
  19. Wang S, Shen J, Yang Y. MRSA in China: Epidemiology, resistance mechanisms, and control strategies. Chin J Antibiot. 2021;46(9):837–844.
  20. Zhou W, Wen Z, Zhu W. Factors associated with clinical antimicrobial resistance in China: A nationwide analysis. Infect Dis Poverty. 2025;14:27.
  21. Sweileh WM, Al-Jabi SW, Zyoud SH. Global research output in antimicrobial resistance among uropathogens: A bibliometric analysis (2002–2016). J Glob Antimicrob Resist. 2017;11:230–238.
  22. Cui L, Li Y, Cheng L. Effectiveness of an antimicrobial stewardship program in reducing antimicrobial use and microbial resistance in a tertiary hospital in China. J Glob Antimicrob Resist. 2019;17:168–174.
  23. Yang Y, Li Y, Wang Z. Machine learning-enabled prediction of antimicrobial resistance from whole-genome sequencing data. J Clin Microbiol. 2021;59(10):e00821-21.
  24. Bhattacharya R, et al. Artificial intelligence for sustainable solutions in combating antimicrobial resistance through data driven health innovations. Discov Public Health. 2026;23(1):10.
  25. Yosef I, Manor M, Kiro R. Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria. Proc Natl Acad Sci U S A. 2015;112(23):7267–7272.
  26. Shou TJ, Cheng XQ, Gong S. Analysis of antimicrobial use strategy in childhood perforated appendicitis based on bacterial resistance changes. Chin Gen Pract. 2020;23(24):3070–3074.
  27. China Antimicrobial Resistance Surveillance System. Surveillance of antimicrobial resistance in bacteria isolated from cerebrospinal fluid specimens from 2020 to 2024. Chin J Infect Chemother. 2026;26(2):196–205.
  28. Gao YH, Ma XY, Wang DB. Distribution and drug resistance of pathogens causing acute bacterial conjunctivitis in children. J Pathog Biol. 2024;19(10):1194–1197.
  29. Zhang Y, Fan YY, Yao LH. Drug resistance and risk factors of multidrug-resistant bacteria in neonatal pneumonia. J Pathog Biol. 2020;15(11):1340–1343.
  30. Duan MB, He XZ, Qi JY. Research progress on anti-multidrug resistant bacteria drugs. J Shenyang Pharm Univ. 2023;40(12):1680–1690.
  31. Zhou LC, Li GQ, Xu BY. Distribution and drug resistance of pathogens in acute, delayed and chronic periprosthetic joint infections. Chin J Surg. 2021;59(6):484–490.
  32. Zhang XX, Ge W, Yang M. Analysis of resistance of 137 Neisseria gonorrhoeae strains to 5 antimicrobial agents. Chin J Dermatovenereol. 2022;36(2):199–203.
  33. Zhang XY, Han Y, Wang YM. Correlation analysis between antimicrobial resistance of Pseudomonas aeruginosa and antimicrobial use density. J Hebei Univ Nat Sci Ed. 2021;41(2):188–194.
  34. China Antimicrobial Resistance Surveillance System. Antimicrobial resistance surveillance report of common clinical isolates from elderly patients from 2014 to 2019. Chin J Infect Control. 2021;20(2):112–123.
  35. Ruan ZH, Huang AX, Wang XJ. Overview of CLSI, EUCAST and Chinese drug resistance judgment standards. Biotechnol Bull. 2022;38(9):47–58.
  36. Liu L, Feng CX, Wang Y. Analysis of bacterial resistance in the First Hospital of Qiqihar in 2016. Chin J Antibiot. 2021;46(12):1143–1147.
  37. Zhang XH, Chen JY, Yang H. Distribution and antimicrobial resistance of pathogens in early infection after lung transplantation in respiratory intensive care unit. Chin J Infect Control. 2020;19(9):785–790.
  38. Wang SS, Wu ZW, Zhao JP. Research progress on hospital infection, drug resistance and treatment of carbapenem-resistant Klebsiella pneumoniae. Chin J Antibiot. 2020;45(5):428–432.
  39. Lv YF, Xue M, Huang XY. Research progress on antimicrobial peptides combined with traditional antibiotics against bacterial resistance. Chin J Infect Control. 2023;22(10):1266–1273.
  40. Ma Y, Liu Y, Jiang M. Correlation analysis between biofilm formation and antimicrobial resistance of Cutibacterium acnes. Chin J Infect Chemother. 2021;21(6):703–707.
  41. Peng Q, Ling BD. Regulatory non-coding RNAs and antimicrobial resistance in Acinetobacter baumannii. Chin J Infect Control. 2021;20(12):1174–1178.
  42. Qin XH, Hao M, Wang MG. Research progress on new antimicrobial agents. Chin J Infect Chemother. 2024;24(4):489–496.
  43. Guo Y, Ding L, Hu FP. CHINET surveillance of bacterial resistance in China in 2024. Chin J Infect Chemother. 2025;25(6):597–607.
  44. Ananth S, Adeoti A, Ray A. Healthcare worker views on antimicrobial resistance in chronic respiratory disease. Eur Respir J. 2024;64(68):2.
  45. Holt KE. Microbial genomics for antimicrobial resistance ecology and action. Nat Rev Genet. 2026;27(1):7–8.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

China AMR TrendsCo-Authorship NetworkKeyword Co-OccurrenceCluster AnalysisCarbapenem ResistanceMethicillin ResistanceAntimicrobial Stewardship